---
title: "Brimonidine - Rosacea - 2"
sidebar: mydoc_sidebar
permalink: db00484-mesh-d012393-2.html
toc: false 
---


Path ID: `DB00484_MESH_D012393_2`
{% include image.html url="images/db00484-mesh-d012393-2.png" file="db00484-mesh-d012393-2.png" alt="db00484-mesh-d012393-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000068438 | brimonidine | Drug |
| MESH:D018341 | Receptors, Adrenergic, alpha-2 | GeneFamily |
| REACT:R-HSA-418594 | G alpha (i) signalling events | Pathway |
| REACT:R-HSA-418597 | G alpha (z) signalling events | Pathway |
| CHEBI:17489 | 3,5-cyclic AMP | ChemicalSubstance |
| GO:0042310 | vasoconstriction | BiologicalProcess |
| HP:0031284 | Flushing | PhenotypicFeature |
| HP:0001041 | Facial erythema | PhenotypicFeature |
| MESH:D012393 | Rosacea | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Brimonidine | INCREASES ACTIVITY OF | Receptors, Adrenergic, Alpha-2 |
| Receptors, Adrenergic, Alpha-2 | PARTICIPATES IN | G Alpha (I) Signalling Events |
| Receptors, Adrenergic, Alpha-2 | PARTICIPATES IN | G Alpha (Z) Signalling Events |
| G Alpha (I) Signalling Events | DECREASES ABUNDANCE OF | 3,5-Cyclic Amp |
| G Alpha (Z) Signalling Events | DECREASES ABUNDANCE OF | 3,5-Cyclic Amp |
| 3,5-Cyclic Amp | NEGATIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | NEGATIVELY CORRELATED WITH | Facial Erythema |
| Vasoconstriction | NEGATIVELY CORRELATED WITH | Flushing |
| Flushing | POSITIVELY CORRELATED WITH | Rosacea |
| Facial Erythema | POSITIVELY CORRELATED WITH | Rosacea |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00484#mechanism-of-action](https://go.drugbank.com/drugs/DB00484#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action](https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Rosacea#Medications](https://en.wikipedia.org/wiki/Rosacea#Medications)
  - [https://pubmed.ncbi.nlm.nih.gov/26566370/](https://pubmed.ncbi.nlm.nih.gov/26566370/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00484#mechanism-of-action](https://go.drugbank.com/drugs/DB00484#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action](https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Rosacea#Medications](https://en.wikipedia.org/wiki/Rosacea#Medications)
  - [https://pubmed.ncbi.nlm.nih.gov/26566370/](https://pubmed.ncbi.nlm.nih.gov/26566370/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00484#mechanism-of-action](https://go.drugbank.com/drugs/DB00484#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action](https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Rosacea#Medications](https://en.wikipedia.org/wiki/Rosacea#Medications)
  - [https://pubmed.ncbi.nlm.nih.gov/26566370/](https://pubmed.ncbi.nlm.nih.gov/26566370/)

Reference: 
  - [https://go.drugbank.com/drugs/DB00484#mechanism-of-action](https://go.drugbank.com/drugs/DB00484#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action](https://en.wikipedia.org/wiki/Brimonidine#Mechanism_of_action)
  - [https://en.wikipedia.org/wiki/Rosacea#Medications](https://en.wikipedia.org/wiki/Rosacea#Medications)
  - [https://pubmed.ncbi.nlm.nih.gov/26566370/](https://pubmed.ncbi.nlm.nih.gov/26566370/)
